Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment With Eribulin

Quantitative model-based analyses are helpful to support decision-making in drug development. In oncology, disease progression/clinical outcome (DPCO) models have been used for early predictions of clinical outcome, but most of such approaches did not include adverse events or dose intensity. In add...

Descripción completa

Detalles Bibliográficos
Autores principales: van Hasselt, JGC, Gupta, A, Hussein, Z, Beijnen, JH, Schellens, JHM, Huitema, ADR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544051/
https://www.ncbi.nlm.nih.gov/pubmed/26312161
http://dx.doi.org/10.1002/psp4.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544051/
https://www.ncbi.nlm.nih.gov/pubmed/26312161
http://dx.doi.org/10.1002/psp4.48

Ejemplares similares